Masimo ROA 2007-2018 | MASI

Current and historical return on assets (ROA) values for Masimo (MASI) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Masimo ROA for the three months ending June 30, 2018 was 17.18%.
Masimo ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-06-30 $0.13B $1.01B 13.27%
2018-03-31 $0.13B $0.95B 13.78%
2017-12-31 $0.13B $0.91B 14.73%
2017-09-30 $0.35B $0.91B 40.10%
2017-06-30 $0.34B $0.90B 42.05%
2017-03-31 $0.33B $0.88B 44.20%
2016-12-31 $0.30B $0.82B 44.86%
2016-09-30 $0.11B $0.64B 17.85%
2016-06-30 $0.10B $0.60B 16.81%
2016-03-31 $0.09B $0.62B 15.09%
2015-12-31 $0.08B $0.60B 14.19%
2015-09-30 $0.08B $0.58B 13.90%
2015-06-30 $0.08B $0.58B 13.48%
2015-03-31 $0.07B $0.58B 13.08%
2014-12-31 $0.07B $0.57B 14.21%
2014-09-30 $0.06B $0.53B 12.65%
2014-06-30 $0.06B $0.50B 13.59%
2014-03-31 $0.07B $0.46B 15.09%
2013-12-31 $0.06B $0.44B 14.04%
2013-09-30 $0.06B $0.43B 16.12%
2013-06-30 $0.06B $0.40B 15.80%
2013-03-31 $0.06B $0.39B 16.22%
2012-12-31 $0.06B $0.38B 16.30%
2012-09-30 $0.06B $0.41B 16.14%
2012-06-30 $0.06B $0.38B 16.79%
2012-03-31 $0.06B $0.38B 16.85%
2011-12-31 $0.06B $0.37B 18.03%
2011-09-30 $0.07B $0.37B 19.35%
2011-06-30 $0.07B $0.35B 20.35%
2011-03-31 $0.06B $0.33B 20.22%
2010-12-31 $0.07B $0.31B 23.76%
2010-09-30 $0.07B $0.33B 22.27%
2010-06-30 $0.07B $0.30B 21.18%
2010-03-31 $0.07B $0.29B 20.63%
2009-12-31 $0.05B $0.36B 16.15%
2009-09-30 $0.04B $0.34B 12.16%
2009-06-30 $0.04B $0.32B 12.83%
2009-03-31 $0.04B $0.31B 12.86%
2008-12-31 $0.03B $0.29B 12.28%
2008-09-30 $0.04B $0.27B 17.87%
2008-06-30 $0.04B $0.25B 16.19%
2008-03-31 $0.03B $0.23B 13.92%
2007-12-31 $0.02B $0.24B 14.49%
2007-09-30 $0.02B $0.23B 15.04%
2007-06-30 $0.01B $0.17B 27.59%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $5.998B $0.798B
Masimo Corporation is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, medical devices, and a wide array of sensors. They believe that Masimo SET helps clinicians monitor in excess of approximately million patients in healthcare settings around the world, and is the pulse oximeter technology used by the top hospitals. Masimo as a private `garage start-up` company because they convinced that the use of adaptive signal processing in the measurement of physiological parameters could solve the problems of low perfusion and motion, which had long plagued in-vivo monitoring and especially pulse oximetry, the measurement of the oxygen saturation of arterial blood. His solution, Masimo SET Measure-through Motion and Low Perfusion pulse oximetry, was shown in a study comparing three pulse oximetry technologies to demonstrate the highest sensitivity and specificity in identifying desaturation events during conditions of motion and low perfusion.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $90.939B 21.81
Intuitive Surgical (ISRG) United States $58.172B 57.46
Edwards Lifesciences (EW) United States $31.263B 35.22
Fresenius Medical Care (FMS) Germany $24.522B 17.32
IDEXX Laboratories (IDXX) United States $19.031B 57.84
ABIOMED (ABMD) United States $16.434B 134.63
DexCom (DXCM) United States $11.613B 0.00
Hologic (HOLX) United States $11.043B 18.79
Teleflex (TFX) United States $11.013B 26.20
Varian Medical Systems (VAR) United States $9.564B 24.07
STERIS (STE) United Kingdom $8.935B 24.58
LivaNova (LIVN) United Kingdom $5.576B 33.26
Integra LifeSciences Holdings (IART) United States $5.290B 27.37
Globus Medical (GMED) United States $5.231B 34.80
Penumbra (PEN) United States $4.703B 427.50
Inogen (INGN) United States $4.332B 114.62
Cantel Medical (CMD) United States $3.433B 34.58
Wright Medical Group (WMGI) Netherlands $2.942B 0.00
Halyard Health (AVNS) United States $2.854B 23.49
Integer Holdings (ITGR) United States $2.390B 21.64
Glaukos (GKOS) United States $2.159B 0.00
Opko Health (OPK) United States $2.004B 0.00
Tandem Diabetes Care (TNDM) United States $1.942B 0.00
Mazor Robotics (MZOR) Israel $1.524B 0.00
Nevro (NVRO) United States $1.481B 0.00
AxoGen (AXGN) United States $1.309B 0.00
Luminex (LMNX) United States $1.245B 36.72
K2Ms (KTWO) United States $1.189B 0.00
Tactile Systems Technology (TCMD) United States $1.183B 201.59
CryoLife (CRY) United States $1.163B 102.00
Orthofix (OFIX) United States $1.083B 33.00
Natus Medical (BABY) United States $1.048B 22.23
TransEnterix (TRXC) United States $0.869B 0.00
Accelerate Diagnostics (AXDX) United States $0.868B 0.00
Intersect ENT (XENT) United States $0.844B 0.00
AngioDynamics (ANGO) United States $0.740B 25.90
Mesa Laboratories (MLAB) United States $0.701B 43.33
ViewRay (VRAY) United States $0.646B 0.00
Sientra (SIEN) United States $0.630B 0.00
Pacific Biosciences Of California (PACB) United States $0.566B 0.00
Neuronetics (STIM) United States $0.438B 0.00
OrthoPediatrics (KIDS) United States $0.426B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.422B 0.00
Veracyte (VCYT) United States $0.353B 0.00
Quotient (QTNT) Switzerland $0.342B 0.00
GenMark Diagnostics (GNMK) United States $0.328B 0.00
Accuray (ARAY) United States $0.320B 0.00
Fluidigm (FLDM) United States $0.298B 0.00
RTI Surgical (RTIX) United States $0.298B 58.75
Nuvectra (NVTR) United States $0.296B 0.00
IRadimed (IRMD) United States $0.280B 100.89
Corindus Vascular Robotics (CVRS) United States $0.249B 0.00
SeaSpine Holdings (SPNE) United States $0.245B 0.00
Helius Medical Technologies (HSDT) United States $0.238B 0.00
T2 Biosystems (TTOO) United States $0.231B 0.00
CRH Medical (CRHM) Canada $0.229B 28.64
Invuity (IVTY) United States $0.178B 0.00
Pulse Biosciences (PLSE) United States $0.157B 0.00
RA MEDICAL SYST (RMED) United States $0.145B 0.00
Alphatec Holdings (ATEC) United States $0.136B 0.00
Apollo Endosurgery (APEN) United States $0.136B 0.00
Ekso Bionics Holdings (EKSO) United States $0.123B 0.00
Viveve Medical (VIVE) United States $0.108B 0.00
Second Sight Medical Products (EYES) United States $0.107B 0.00
Sensus Healthcare (SRTS) United States $0.098B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.096B 0.00
EDAP TMS (EDAP) France $0.084B 0.00
Biosig Technologies (BSGM) United States $0.073B 0.00
ConforMIS (CFMS) United States $0.057B 0.00
Restoration Robotics (HAIR) United States $0.054B 0.00
Electromed (ELMD) United States $0.053B 26.75
OBALON THERPTCS (OBLN) United States $0.044B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.043B 0.00
Xtant Medical Holdings (XTNT) United States $0.041B 0.00
Neovasc (NVCN) Canada $0.038B 0.00
Vermillion (VRML) United States $0.037B 0.00
Lianluo Smart (LLIT) China $0.034B 0.00
PAVmed (PAVM) United States $0.030B 0.00
ReWalk Robotics (RWLK) Israel $0.028B 0.00
Titan Medical (TMDI) Canada $0.027B 0.00
ENDRA Life Sciences (NDRA) United States $0.024B 0.00
DarioHealth (DRIO) Israel $0.023B 0.00
Dynatronics (DYNT) United States $0.022B 0.00
Presbia (LENS) Ireland $0.021B 0.00
American Shared Hospital Services (AMS) United States $0.019B 15.36
Nanovibronix (NAOV) United States $0.017B 0.00
Microbot Medical (MBOT) United States $0.016B 0.00
Bioanalytical Systems (BASI) United States $0.015B 0.00
Avinger (AVGR) United States $0.011B 0.00
Micron Solutions (MICR) United States $0.010B 0.00
Allied Healthcare Products (AHPI) United States $0.008B 0.00
Sunshine Heart Inc (CHFS) United States $0.008B 0.00
Cesca Therapeutics (KOOL) United States $0.008B 0.00
Atossa Genetics (ATOS) United States $0.008B 0.00
InspireMD (NSPR) Israel $0.006B 0.00
Amedica (AMDA) United States $0.004B 0.00
EnteroMedics (RSLS) United States $0.000B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00